These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30195637)

  • 41. Comprehensive Analysis of Survival-Related lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Gastric Cancer.
    Zhao Y; Zhang H; Ju Q; Li X; Zheng Y
    Front Genet; 2021; 12():610501. PubMed ID: 33737947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Potential Novel Prognosis-Related Genes Through Transcriptome Sequencing, Bioinformatics Analysis, and Clinical Validation in Acute Myeloid Leukemia.
    Wang J; Uddin MN; Hao JP; Chen R; Xiang YX; Xiong DQ; Wu Y
    Front Genet; 2021; 12():723001. PubMed ID: 34777462
    [No Abstract]   [Full Text] [Related]  

  • 43. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma.
    Dou D; Yang S; Lin Y; Zhang J
    Cancer Biomark; 2018; 23(1):79-93. PubMed ID: 29991127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptome sequencing in a 6-hydroxydopamine rat model of Parkinson's disease.
    Li J; Sun Y; Chen J
    Genes Genet Syst; 2019 Apr; 94(2):61-69. PubMed ID: 30713215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Li HM; Liu Y; Ding JY; Zhang R; Liu XY; Shen CL
    Front Med (Lausanne); 2020; 7():583243. PubMed ID: 33195333
    [No Abstract]   [Full Text] [Related]  

  • 47. Comprehensive analysis of tumor immune infiltration associated with endogenous competitive RNA networks in lung adenocarcinoma.
    Wei B; Kong W; Mou X; Wang S
    Pathol Res Pract; 2019 Jan; 215(1):159-170. PubMed ID: 30466766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature.
    Sheng WH; Sheng KT; Zhao YX; Li H; Zhou JL; Yao HY; Li XH
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3635-42. PubMed ID: 26502853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
    Wang JY; Wang CL; Wang XM; Liu FJ
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2114-2129. PubMed ID: 28537673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioinformatics analysis to identify the critical genes, microRNAs and long noncoding RNAs in melanoma.
    Zhang Q; Wang Y; Liang J; Tian Y; Zhang Y; Tao K
    Medicine (Baltimore); 2017 Jul; 96(29):e7497. PubMed ID: 28723760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic signatures for renal cancer as identified by long non-coding and miRNA competing endogenous network analysis.
    Gao H; Chen X; Shang Z; Niu Y
    Oncol Rep; 2018 Aug; 40(2):959-967. PubMed ID: 29901101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Whole-Transcriptome Sequencing Identifies Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs Associated with CHOL.
    Chu KJ; Ma YS; Jiang XH; Wu TM; Wu ZJ; Li ZZ; Wang JH; Gao QX; Yi B; Shi Y; Wang HM; Gu LP; Zhang SQ; Wang GR; Liu JB; Fu D; Jiang XQ
    Mol Ther Nucleic Acids; 2020 Sep; 21():592-603. PubMed ID: 32721879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of aberrant miRNA-mRNA interaction networks in prostate cancer to conjecture its molecular mechanisms.
    Peng S; Liu C; Fan X; Zhu J; Zhang S; Zhou X; Wang T; Gao F; Zhu W
    Cancer Biomark; 2022; 35(4):395-407. PubMed ID: 36373308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer-related long noncoding RNAs show aberrant expression profiles and competing endogenous RNA potential in esophageal adenocarcinoma.
    Yu Y; Chen X; Cang S
    Oncol Lett; 2019 Nov; 18(5):4798-4808. PubMed ID: 31611990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrated analysis of noncoding RNAs and mRNAs reveals their potential roles in the biological activities of the growth hormone receptor.
    Chang L; Qi H; Xiao Y; Li C; Wang Y; Guo T; Liu Z; Liu Q
    Growth Horm IGF Res; 2016 Aug; 29():11-20. PubMed ID: 27064376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
    Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
    Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of potential prognostic long non‑coding RNA signatures based on a competing endogenous RNA network in lung adenocarcinoma.
    Wang X; Ding Y; Da B; Fei Y; Feng G
    Oncol Rep; 2018 Dec; 40(6):3199-3212. PubMed ID: 30272355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective lncRNA-miRNA-mRNA regulatory network of long non-coding RNA LINC00968 in non-small cell lung cancer A549 cells: A miRNA microarray and bioinformatics investigation.
    Li DY; Chen WJ; Luo L; Wang YK; Shang J; Zhang Y; Chen G; Li SK
    Int J Mol Med; 2017 Dec; 40(6):1895-1906. PubMed ID: 29039552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA AP000842.3 Triggers the Malignant Progression of Prostate Cancer by Regulating Cuproptosis Related Gene NFAT5.
    Zhou G; Chen C; Wu H; Lin J; Liu H; Tao Y; Huang B
    Technol Cancer Res Treat; 2024; 23():15330338241255585. PubMed ID: 38780486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma.
    Wu X; Ruan L; Yang Y; Mei Q
    Mol Cell Probes; 2016 Jun; 30(3):146-52. PubMed ID: 26928440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.